Abbott agreed to pay $384,999,040 to settle False Claims Act allegations over infant formula. The headline measured -0.628% in ten minutes, and the stock still closed up 1.12% as health care stocks rose.
US markets live · September 14, 2026
Material developments only. Each item passed independent evidence and Google News compliance checks.
Bank of America closed down 5.14% on Monday after Brian Moynihan put third-quarter investment banking fees at $1.6 billion to $1.8 billion, below $2.0 billion a year earlier. The first headline measured -1.144% in ten minutes.
Sysco fell 2.621% in the ten minutes after a $1 billion common stock offering crossed at 16:21:00 ET, measured from its $83.54 close. The proceeds help fund the $29.1 billion Jetro Restaurant Depot deal.
High Tide reported record Q3 revenue of C$198.8 million and adjusted EBITDA of C$16.2 million, both inside ranges it published on August 4. The stock was 2.044% lower after hours, 10 minutes after the 16:04:11 ET release.
Veracyte acquired Convergent Genomics and its UroAmp urine test for $150 million in cash plus up to $30 million in milestones, with a first test planned for late 2028. The stock closed up 0.83% before the news.
Kestra grew fiscal first-quarter revenue 60% to $31.0 million and raised guidance to $141 million, but its adjusted loss widened to $0.75 a share. The stock was 7.733% lower after hours, 10 minutes after the 16:01:48 ET release.
The J&J-partnered Phase 2 MOONLIGHT-1 trial of JNJ-5120 (PIPE-307) in depression missed its primary endpoint. Contineum traded at $14.00 ten minutes into after-hours trading, 5.533% below the $14.82 close.
Dave & Buster's posted an adjusted loss of $0.27 a share for fiscal Q2 2026 as revenue fell 2.4% and comparable sales dropped 2.9%. The stock was 14.588% lower after hours, 10 minutes after the 16:05:51 ET release.
The Children's Place missed second-quarter sales and loss estimates, and its 34.6% adjusted gross margin included $39 million of tariff refunds. The stock was 9.274% lower after hours, 10 minutes after the 16:30:01 ET release.
Coda Octopus grew fiscal third-quarter revenue 9.2% to about $7.7 million while its core marine technology business fell 15.2% for a second straight decline. The stock was 0.97% higher ten minutes after the 07:00 ET release. As of 12:38 ET it was +3.37% against Friday's close.
Volato closed its merger with AI data center developer Alignment Engine, whose holders will own about 95% of the company once their preferred converts. The stock was 15.471% higher ten minutes after the 08:05 ET headline. As of 12:37 ET it was +25.79% against Friday's close.
AirJoule acquired BitSink for $27 million upfront, $18 million of it in cash, plus up to $40 million in stock tied to revenue targets. The stock was already below Friday's close before the 07:00 ET announcement, rose 2.19% on it, and was 3.27% lower on the day by 12:34 ET.
DeFi Development raised its Solana treasury to about 2.39 million SOL and set up a $300 million program to issue CHAD preferred stock at $10.00 or more. The stock was 1.70% higher ten minutes after the 08:30 ET update. As of 12:32 ET it was +2.34% against Friday's close.
RF Industries reported record fiscal third-quarter sales of $23.96 million, adjusted EPS a cent below estimates and bookings below sales. The stock was 6.25% lower one minute after the 08:00 ET release and 8.36% lower after ten.
The FDA granted RMAT designation to Tenaya's TN-401 gene therapy for PKP2-associated ARVC. The stock was up 8.91% on the session at 12:29 ET.
Mokulele Airlines won a four-year, $19.4 million federal subsidy contract to keep serving Lanai, Hawaii. The stock was 11.3% higher one minute after the 06:30 ET headline and 9.34% higher after ten. By 12:28 ET it was 5.03% below Friday's close.
Perspective signed a supply agreement with Merck to test [212Pb]PSV359 with Keytruda in FAP-α positive tumors. The stock was up 2.31% on the session at 12:26 ET, below its $3.79 February offering price.
Caliber refinanced about $3.4 million of corporate notes and secured a six-month option to retire $9.1 million more for about $7.3 million in cash. The stock was 7.681% higher one minute after the 07:30 ET headline.
The FDA cleared Nasus Pharma's IND for NS002, its nasal epinephrine powder for anaphylaxis, ahead of a pivotal study planned for the fourth quarter of 2026. The stock was up 10.13% at 12:24 ET.
RUM Group shares were up 15.20% at 12:20 ET Monday after The Information reported that Anthropic is the customer behind the $13.7 billion computing contract the company disclosed in August without a name.
The FDA cleared Beta Bionics' Mint patch pump for a planned first-quarter 2027 launch. The stock dropped to $14.24 before the open and was up 4.34% on the session at 12:22 ET.
Tyra priced a $400.0 million stock and pre-funded warrant offering at $22.03 five days after its SURF302 bladder cancer data. The shares were up 15.66% on the session at 12:21 ET.
ArcelorMittal halted primary steel production at Kryvyi Rih after the second missile strike on the plant in five weeks. Its shares moved about as much as Europe's steel peers.
Corbus reported 5.0% placebo-adjusted weight loss at 12 weeks for oral CRB-913 at 60 mg in CANYON-1. The stock swung between $9.91 and $5.56 in the minutes after the release and was up 2.40% on the session at 12:16 ET.